{"topic_id":"ade_climbazole_adverse_events","category":"ade","context":"---\ntopic_id: ade_climbazole_adverse_events\ncategory: ade\ntitle: \"FDA ADE reports for Climbazole (active ingredient) — total reports, species & reaction breakdown\"\nlang: en\nsource: \"openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22\"\nsource_file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b18.json\ndate_parsed: 2026-07-22\ntokens_estimated: 344\nverification:\n  method: substring_match\n  claims: 28\n  passed: 28\n  date: 2026-07-22\n---\n\n# Climbazole — FDA Animal & Veterinary Adverse Event (ADE) Reports\n\nSource: openFDA `animalandveterinary/event.json`, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Climbazole is a active ingredient.\n\n## Total reports\nClimbazole: 224\n\n## Reports by species (top entries)\n- Dog 188\n- Cat 24\n- Human 12\n\n## Top reported reactions (VEDDRA terms, top entries)\n- Application site erythema 58\n- Application site pruritus 24\n- Application site irritation 14\n- Application site reddening 13\n- Pruritus 11\n- Erythema (for urticaria see Immune SOC) 8\n- Application site dermatitis 7\n- Application site inflammation 7\n- Application site pain 7\n- Application site hair coat discolouration 6\n\nSource JSON: `pdf-raw/ade/ade_active_ingredients_2026-07-22_b18.json` (openFDA animalandveterinary/event.json, pulled 2026-07-22).\n","sources":[],"tokens_estimated":248,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}